Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Effect of Haishengsu as an Adjunct Therapy for Patients with Advanced Renal Cell Cancer: A Randomized and Placebo-Controlled Clinical Trial
Journal of Alternative and Complementary Medicine, 10/15/09
Liu JS et al. – Addition of Haishengsu to the conventional immunotherapy is associated with an increased remission rate in patients with advanced renal cell cancer. Haishengsu was also associated with a reduced rate of gastrointestinal side–effects from the immunotherapeutic agents, and an improvement in the physical functionality of the patients.
Related Articles
Primary Renal Zygomycotic Infarction Mimicking Renal Neoplasia in an Immunocompetent Patient
The American Journal of the Medical Sciences, 10/20/09
Relevance Score: 64%
Childhood cancer mortality in Europe, 1970–2007
European Journal of Cancer, 10/14/09
Relevance Score: 64%
Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
Journal of Korean Medical Science, 11/16/09
Relevance Score: 62%
The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 47%
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 47%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Birt-Hogg-Dube syndrome: diagnosis and management
The Lancet Oncology, 12/04/09
Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram
Journal of Clinical Oncology, 12/04/09
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09
Article Search
Sponsor


See Latest Articles


